首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P3.02a-022 Experiences of Patients Receiving Treatment with Ceritinib to Treat ALK+ Non-Small Cell Lung Cancer: A Qualitative Study

【24h】

P3.02a-022 Experiences of Patients Receiving Treatment with Ceritinib to Treat ALK+ Non-Small Cell Lung Cancer: A Qualitative Study

机译：P3.02A-022患者接受Ceritinib治疗治疗Alk +非小细胞肺癌的经验：定性研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
作者
Jennifer Devlen; France Ginchereau Sowell; Gabrielle Quiggle; Emuella Flood; Kenneth Culver; Anand Dalal;
展开▼
作者单位

Icon Clinical Research;

Icon Clinical Research;

Icon Clinical Research;

Icon Clinical Research;

Novartis;

Novartis;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P3.02a-022 Experiences of Patients Receiving Treatment with Ceritinib to Treat ALK+ Non-Small Cell Lung Cancer: A Qualitative Study [J] . Jennifer Devlen, France Ginchereau Sowell, Gabrielle Quiggle, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02A-022患者接受Ceritinib治疗治疗Alk +非小细胞肺癌的经验：定性研究
2. P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study [J] . Edmond Bendaly, Anand Dalal, Kenneth Culver, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02A-023 Alk +非小细胞肺癌患者的治疗模式和早期结果接受CERITINIB：图表审查研究
3. P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study [J] . Edmond Bendaly, Anand Dalal, Kenneth Culver, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02A-023 Alk +非小细胞肺癌患者的治疗模式和早期结果接受CERITINIB：图表审查研究
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients [O] . Jacques Cadranel, Alexis B. Cortot, Hervé Lena, 2018

机译：赛瑞替尼在克唑替尼预处理的ALK +晚期非小细胞肺癌患者中的真实生活经验
7. P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study [O] . Edmond Bendaly, Anand Dalal, Kenneth Culver, 2017

机译：P3.02A-023 Alk +非小细胞肺癌患者的治疗模式和早期结果接受CERITINIB：图表审查研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号